Effect of Porphyromonas gingivalis lipopolysaccharide administration on non-alcoholic liver disease in Medaka fish

牙龈卟啉单胞菌脂多糖给药对青鳉鱼非酒精性肝病的影响

阅读:2

Abstract

Recently, it has been reported that either infection of rodents with the periodontopathogenic Porphyromonas gingivalis (Pg) or administration of its lipopolysaccharide (Pg-LPS) to rodents with non-alcoholic steatohepatitis (NASH) causes progression and exacerbation of the disease. Thus, periodontal disease and NASH are closely related, and further research is required. Medaka (Oryzias latipes) has been used as an alternative model for studying human diseases in rodents. In this study, we investigated the association between NASH and Pg-LPS in a NASH model medaka, fed a high-fat diet for 12 weeks, and then injected intraperitoneally with Pg-LPS (low-dose Pg-LPS group: 1.5 mg/kg, high-dose Pg-LPS group: 15 mg/kg) once a week from 5 to 8 weeks. After 12 weeks, the effects of Pg-LPS administration on NASH pathology were evaluated. As a result, liver weight and liver weight/body weight values tended to be higher in the high-dose Pg-LPS group compared to the other groups. HE and Oil Red O staining of the liver showed increased fat accumulation with high-dose Pg-LPS. In addition, Sirius red staining of the liver found fibrosis only in the high-dose Pg-LPS group. These results suggest that Pg-LPS administration may accelerate the progression of the disease in the NASH model medaka.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。